Thermo Fisher Scientific (TMO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 9 |
| Ownership rank: | 29 |
| % of all portfolios: | 0.279% |
| Hold Price * : | $520.23 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
2 |
$11,038 |
| Sells |
96 |
$87,150,149 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Lindsell Train |
5.30 |
Buy |
407,240 |
211,858,000 |
| ≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
4.28 |
|
75,000 |
39,017,000 |
| ≡ |
Polen Capital Management |
3.46 |
Reduce 12.31% |
2,461,195 |
1,280,388,000 |
| ≡ |
William Von Mueffling - Cantillon Capital Management |
2.92 |
Add 16.38% |
929,870 |
483,746,000 |
| ≡ |
Daniel Loeb - Third Point |
2.48 |
Buy |
350,000 |
182,081,000 |
| ≡ |
AKO Capital |
2.26 |
Reduce 25.90% |
313,784 |
163,240,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
1.11 |
Reduce 1.50% |
19,456 |
10,122,000 |
| ≡ |
Thomas Gayner - Markel Group |
0.19 |
Add 16.10% |
41,100 |
21,381,000 |
| ≡ |
Torray Funds |
0.03 |
|
403 |
210,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 21 Feb 2025 |
CHAI NELSON |
Director |
09 Dec 2024 |
4 |
535.93 |
2,144 |
| 21 Feb 2025 |
CHAI NELSON |
Director |
07 Nov 2024 |
16 |
555.89 |
8,894 |
| 06 Oct 2023 |
BOXER MICHAEL A |
SVP and General Counsel |
26 Jun 2023 |
4 |
526.15 |
2,105 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock